Overexpression of CUG triplet repeat-binding protein, CUGBP1, in mice inhibits myogenesis
- PMID: 14722059
- DOI: 10.1074/jbc.M312923200
Overexpression of CUG triplet repeat-binding protein, CUGBP1, in mice inhibits myogenesis
Abstract
Accumulation of RNA CUG repeats in myotonic dystrophy type 1 (DM1) patients leads to the induction of a CUG-binding protein, CUGBP1, which increases translation of several proteins that are required for myogenesis. In this paper, we examine the role of overexpression of CUGBP1 in DM1 muscle pathology using transgenic mice that overexpress CUGBP1 in skeletal muscle. Our data demonstrate that the elevation of CUGBP1 in skeletal muscle causes overexpression of MEF2A and p21 to levels that are significantly higher than those in skeletal muscle of wild type animals. A similar induction of these proteins is observed in skeletal muscle of DM1 patients with increased levels of CUGBP1. Immunohistological analysis showed that the skeletal muscle from mice overexpressing CUGBP1 is characterized by a developmental delay, muscular dystrophy, and myofiber-type switch: increase of slow/oxidative fibers and the reduction of fast fibers. Examination of molecular mechanisms by which CUGBP1 up-regulates MEF2A shows that CUGBP1 increases translation of MEF2A via direct interaction with GCN repeats located within MEF2A mRNA. Our data suggest that CUGBP1-mediated overexpression of MEF2A and p21 inhibits myogenesis and contributes to the development of muscle deficiency in DM1 patients.
Similar articles
-
Molecular basis for impaired muscle differentiation in myotonic dystrophy.Mol Cell Biol. 2001 Oct;21(20):6927-38. doi: 10.1128/MCB.21.20.6927-6938.2001. Mol Cell Biol. 2001. PMID: 11564876 Free PMC article.
-
CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1.Hum Mol Genet. 2010 Sep 15;19(18):3614-22. doi: 10.1093/hmg/ddq277. Epub 2010 Jul 5. Hum Mol Genet. 2010. PMID: 20603324 Free PMC article.
-
Correction of GSK3β at young age prevents muscle pathology in mice with myotonic dystrophy type 1.FASEB J. 2018 Apr;32(4):2073-2085. doi: 10.1096/fj.201700700R. Epub 2018 Jan 5. FASEB J. 2018. PMID: 29203592 Free PMC article.
-
Correction of RNA-Binding Protein CUGBP1 and GSK3β Signaling as Therapeutic Approach for Congenital and Adult Myotonic Dystrophy Type 1.Int J Mol Sci. 2019 Dec 21;21(1):94. doi: 10.3390/ijms21010094. Int J Mol Sci. 2019. PMID: 31877772 Free PMC article. Review.
-
The role of CUGBP1 in age-dependent changes of liver functions.Ageing Res Rev. 2012 Sep;11(4):442-9. doi: 10.1016/j.arr.2012.02.007. Epub 2012 Mar 14. Ageing Res Rev. 2012. PMID: 22446383 Free PMC article. Review.
Cited by
-
(1)H, (15)N and (13)C chemical shift assignments of RNA repeats binding protein -- CUGBP1ab.J Biomol NMR. 2004 Nov;30(3):371-2. doi: 10.1007/s10858-005-2598-y. J Biomol NMR. 2004. PMID: 15756469 No abstract available.
-
Heart-specific overexpression of CUGBP1 reproduces functional and molecular abnormalities of myotonic dystrophy type 1.Hum Mol Genet. 2010 Mar 15;19(6):1066-75. doi: 10.1093/hmg/ddp570. Epub 2010 Jan 5. Hum Mol Genet. 2010. PMID: 20051426 Free PMC article.
-
Structural insights into RNA recognition by the alternate-splicing regulator CUG-binding protein 1.Structure. 2010 Oct 13;18(10):1364-77. doi: 10.1016/j.str.2010.06.018. Structure. 2010. PMID: 20947024 Free PMC article.
-
Cutaneous findings in myotonic dystrophy.JAAD Int. 2022 Feb 22;7:7-12. doi: 10.1016/j.jdin.2021.09.008. eCollection 2022 Jun. JAAD Int. 2022. PMID: 35243403 Free PMC article.
-
Most expression and splicing changes in myotonic dystrophy type 1 and type 2 skeletal muscle are shared with other muscular dystrophies.Neuromuscul Disord. 2014 Mar;24(3):227-40. doi: 10.1016/j.nmd.2013.11.001. Epub 2013 Nov 15. Neuromuscul Disord. 2014. PMID: 24332166 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous
